To study cellular and molecular events of cardiac protection by metallothio
nein (MT) from oxidative injury, a primary neonatal cardiomyocyte culture w
as established from a specific cardiac MT-overexpressing transgenic mouse m
odel. Ventricular cardiomyocytes were isolated from 1- to 3-day-old neonata
l mice and cultured in an Eagle's minimum essential medium supplemented wit
h 20% fetal bovine serum under an atmosphere of 5% CO2-95% air at 37 degree
s C. Forty-eight hours after plating was completed, the purity of such cult
ures was 95% myocytes, assessed by an immunocytochemical assay. Over 80% of
the cardiomyocytes beat spontaneously on the first day of culture and sync
hronously in a confluent monolayer after the sixth day of culture. Cellular
MT concentrations in the transgenic cardiomyocytes before culturing and on
the sixth day postculturing were about seven- and twofold higher than nont
ransgenic controls, respectively. However, there were no significant differ
ences in cell morphology, glutathione content, and antioxidant enzymatic ac
tivities between these two types of cardiomyocytes. When these cells were c
hallenged by H2O2, the transgenic cardiomyocytes displayed a significant re
sistance to the toxic effect of this oxidant, as measured by cell viability
, lactate dehydrogenase leakage, and morphological alterations. In addition
, the transgenic cells were highly protected from H2O2-induced lipid peroxi
dation. These observations demonstrate that MT protects the cultured cardio
myocytes from H2O2 toxicity by preventing its interaction with macromolecul
es such as lipids, and this cultured primary neonatal mouse cardiomyocyte s
ystem provides a valuable tool to directly study cellular and molecular eve
nts of MT in cardiac protection against oxidative injury.